Search Results - "Mujagic, Z"

Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study by Vork, L., Weerts, Z. Z. R. M., Mujagic, Z., Kruimel, J. W., Hesselink, M. A. M., Muris, J. W. M., Keszthelyi, D., Jonkers, D. M. A. E., Masclee, A. A. M.

“…Background The Rome criteria for irritable bowel syndrome (IBS) have been revised and are expected to apply only to the subset of Rome III IBS subjects with…”
Get full text

Systematic review: instruments to assess abdominal pain in irritable bowel syndrome by Mujagic, Z., Keszthelyi, D., Aziz, Q., Reinisch, W., Quetglas, E. G., De Leonardis, F., Segerdahl, M., Masclee, A. A. M.

“…Summary Background Consensus on standard methods to assess chronic abdominal pain in patients with irritable bowel syndrome (IBS) is currently lacking. Aim To…”
Get full text

Do antro‐duodenal manometry parameters predict clinical response after gastric peroral endoscopic pyloromyotomy in refractory gastroparesis? by Sweerts, K. W. E., Mujagic, Z., Straathof, J. W. A., Hereijgers, M. J. M., Keszthelyi, D., Conchillo, J. M.

“…Background Gastric peroral endoscopic pyloromyotomy (G‐POEM) is a promising therapeutic modality for refractory gastroparesis (GP). However, as characteristics…”
Get full text

Abdominal pain in patients with inflammatory bowel disease in remission: A prospective study on contributing factors by Janssen, L M, Rezazadeh Ardabili, A, Romberg-Camps, M J L, Winkens, B, van den Broek, R J, Hulst, J, Verwijs, H J A, Keszthelyi, D, Jonkers, D M A E, van Bodegraven, A A, Pierik, M J, Mujagic, Z

“…Abdominal pain is highly prevalent in patients with inflammatory bowel disease (IBD) in remission, but the aetiology is incompletely understood. To…”
Get full text

Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders by Mujagic, Z., Ludidi, S., Keszthelyi, D., Hesselink, M. A. M., Kruimel, J. W., Lenaerts, K., Hanssen, N. M. J., Conchillo, J. M., Jonkers, D. M. A. E., Masclee, A. A. M.

“…Summary Background Intestinal permeability has been studied in small groups of IBS patients with contrasting findings. Aims To assess intestinal permeability…”
Get full text

Alterations in serotonin metabolism in the irritable bowel syndrome by Thijssen, A. Y., Mujagic, Z., Jonkers, D. M. A. E., Ludidi, S., Keszthelyi, D., Hesselink, M. A., Clemens, C. H. M., Conchillo, J. M., Kruimel, J. W., Masclee, A. A. M.

“…Summary Background Alterations in serotonin (5‐HT) metabolism have been postulated to play a role in the pathogenesis of irritable bowel syndrome (IBS)…”
Get full text

Development, content validity, and cross‐cultural adaptation of a patient‐reported outcome measure for real‐time symptom assessment in irritable bowel syndrome by Vork, L., Keszthelyi, D., Mujagic, Z., Kruimel, J. W., Leue, C., Pontén, I., Törnblom, H., Simrén, M., Albu‐Soda, A., Aziz, Q., Corsetti, M., Holvoet, L., Tack, J., Rao, S. S., Os, J., Quetglas, E. G., Drossman, D. A., Masclee, A. A. M.

“…Background End‐of‐day questionnaires, which are considered the gold standard for assessing abdominal pain and other gastrointestinal (GI) symptoms in irritable…”
Get full text

Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach by Baranska, A., Mujagic, Z., Smolinska, A., Dallinga, J. W., Jonkers, D. M. A. E., Tigchelaar, E. F., Dekens, J., Zhernakova, A., Ludwig, T., Masclee, A. A. M., Wijmenga, C., Schooten, F. J.

“…Background The diagnosis of irritable bowel syndrome (IBS) is challenging because of its heterogeneity and multifactorial pathophysiology. No reliable…”
Get full text

Age-Related Changes in Abdominal Pain in Healthy Individuals and IBS Patients by Wilms, Ellen, Jonkers, Daisy, Keszthelyi, Daniel, Mujagic, Z, Vork, Lisa, Weerts, Zsa Zsa, Kruimel, Joanna W, Troost, Freddy, Masclee, Ad

Get full text

A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease by Gacesa, R., Vich Vila, A., Collij, V., Mujagic, Z., Kurilshikov, A., Voskuil, M.D., Festen, E.A.M., Wijmenga, C., Jonkers, D.M.A.E., Dijkstra, G., Fu, J., Zhernakova, A., Imhann, F., Weersma, R.K.

“…Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) show a large overlap in clinical presentation, which presents diagnostic challenges. As a…”
Get full text

Markers for visceral hypersensitivity in patients with irritable bowel syndrome by Ludidi, S., Mujagic, Z., Jonkers, D., Keszthelyi, D., Hesselink, M., Kruimel, J., Conchillo, J., Masclee, A.

“…Background Irritable bowel syndrome (IBS) is a heterogenous disorder with visceral hypersensitivity as important hallmark. It is not known whether IBS patients…”
Get full text

Biomarkers for visceral hypersensitivity in patients with irritable bowel syndrome by Mujagic, Z., Jonkers, D. M. A. E., Ludidi, S., Keszthelyi, D., Hesselink, M. A., Weerts, Z. Z. R. M., Kievit, R. N., Althof, J. F., Leue, C., Kruimel, J. W., Schooten, F. J., Masclee, A. A. M.

“…Background Increased visceral sensitivity is observed in up to 60% of patients with Irritable Bowel Syndrome (IBS). Mucosal inflammation, altered…”
Get full text

Habitual diet and diet quality in Irritable Bowel Syndrome: A case‐control study by Tigchelaar, E. F., Mujagic, Z., Zhernakova, A., Hesselink, M. A. M., Meijboom, S., Perenboom, C. W. M., Masclee, A. A. M., Wijmenga, C., Feskens, E. J. M., Jonkers, D. M. A. E.

“…Background Diet is considered to be a key factor in symptom generation in Irritable Bowel Syndrome (IBS) and patients tend to exclude food products from their…”
Get full text

The Experience Sampling Method ‐ a new digital tool for momentary symptom assessment in IBS: an exploratory study by Mujagic, Z., Leue, C., Vork, L., Lousberg, R., Jonkers, D. M. A. E., Keszthelyi, D., Hesselink, M. A., Schagen, T. J. C., Os, J., Masclee, A. A. M., Kruimel, J. W.

“…Background Retrospective questionnaires are frequently used for symptom assessment in irritable bowel syndrome (IBS) patients, but are influenced by recall…”
Get full text

Editorial: serotonin and irritable bowel syndrome – reconciling pharmacological effects with basic biology; authors' reply by Mujagic, Z., Keszthelyi, D., Thijssen, A. Y., Jonkers, D. M. A. E., Masclee, A. A. M.

Get full text

Mo1671 DO ANTRO-DUODENAL MANOMETRY PARAMETERS PREDICT CLINICAL RESPONSE AFTER GASTRIC PERORAL ENDOSCOPIC PYLOROMYOTOMY IN REFRACTORY GASTROPARESIS? by Sweerts, Kim, Mujagic, Z, Straathof, Jan Willem, Keszthelyi, Daniel, Conchillo, José M.

Get full text

Large-scale association analyses identify host factors influencing human gut microbiome composition by Kurilshikov, Alexander, Medina-Gomez, Carolina, Bacigalupe, Rodrigo, Radjabzadeh, Djawad, Wang, Jun, Demirkan, Ayse, Le Roy, Caroline I., Raygoza Garay, Juan Antonio, Finnicum, Casey T., Liu, Xingrong, Zhernakova, Daria V., Bonder, Marc Jan, Hansen, Tue H., Frost, Fabian, Rühlemann, Malte C., Turpin, Williams, Moon, Jee-Young, Kim, Han-Na, Lüll, Kreete, Barkan, Elad, Shah, Shiraz A., Fornage, Myriam, Szopinska-Tokov, Joanna, Wallen, Zachary D., Borisevich, Dmitrii, Agreus, Lars, Andreasson, Anna, Bang, Corinna, Bedrani, Larbi, Bell, Jordana T., Bisgaard, Hans, Boehnke, Michael, Boomsma, Dorret I., Burk, Robert D., Claringbould, Annique, Croitoru, Kenneth, Davies, Gareth E., van Duijn, Cornelia M., Duijts, Liesbeth, Falony, Gwen, Fu, Jingyuan, van der Graaf, Adriaan, Hansen, Torben, Homuth, Georg, Hughes, David A., Ijzerman, Richard G., Jackson, Matthew A., Jaddoe, Vincent W. V., Joossens, Marie, Jørgensen, Torben, Keszthelyi, Daniel, Knight, Rob, Laakso, Markku, Laudes, Matthias, Launer, Lenore J., Lieb, Wolfgang, Lusis, Aldons J., Masclee, Ad A. M., Moll, Henriette A., Mujagic, Zlatan, Qibin, Qi, Rothschild, Daphna, Shin, Hocheol, Sørensen, Søren J., Steves, Claire J., Thorsen, Jonathan, Timpson, Nicholas J., Vieira-Silva, Sara, Völker, Uwe, Völzke, Henry, Võsa, Urmo, Wade, Kaitlin H., Walter, Susanna, Watanabe, Kyoko, Weiss, Stefan, Weiss, Frank U., Weissbrod, Omer, Westra, Harm-Jan, Willemsen, Gonneke, Payami, Haydeh, Jonkers, Daisy M. A. E., Arias Vasquez, Alejandro, de Geus, Eco J. C., Stokholm, Jakob, Segal, Eran, Kim, Hyung-Lae, Kaplan, Robert C., Spector, Tim D., Uitterlinden, Andre G., Rivadeneira, Fernando, Franke, Andre, Lerch, Markus M., Franke, Lude, Sanna, Serena, D’Amato, Mauro, Pedersen, Oluf, Paterson, Andrew D., Kraaij, Robert, Raes, Jeroen, Zhernakova, Alexandra

“…To study the effect of host genetics on gut microbiome composition, the MiBioGen consortium curated and analyzed genome-wide genotypes and 16S fecal microbiome…”
Get full text

Sa1678: DIETARY ADVANCED GLYCATION ENDPRODUCTS AND INTESTINAL INFLAMMATION IN INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME PATIENTS by Graaf, Marlijne C. de, Scheijen, Jean, Spooren, Corinne, Mujagic, Z, Pierik, Marie J., Keszthelyi, Daniel, Schalkwijk, Casper, Jonkers, Daisy

Get full text

P344 Achieving Crohn's Disease treatment targets following the STRIDE-II recommendations in clinical practice by Aliu, A, Janssen, L, Rezazadeh Ardabili, A, Mujagic, Z, Pierik, M

“…Abstract Background The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative proposes therapeutic targets for inflammatory bowel…”
Get full text

Sa1675: DIET QUALITY AND DIETARY INFLAMMATORY INDEX IN INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME PATIENTS by Graaf, Marlijne C. de, Spooren, Corinne, Hendrix, Evelien, Hesselink, Martine, Feskens, Edith, Pierik, Marie J., Keszthelyi, Daniel, Mujagic, Z, Jonkers, Daisy

Get full text